Korean J Urol.  2010 Jul;51(7):443-449.

Neurologic Factors in Female Sexual Function and Dysfunction

• Azadzoi KM
• Siroky MB

Abstract

Sexual dysfunction affects both men and women, involving organic disorders, psychological problems, or both. Overall, the state of our knowledge is less advanced regarding female sexual physiology in comparison with male sexual function. Female sexual dysfunction has received little clinical and basic research attention and remains a largely untapped field in medicine. The epidemiology of female sexual dysfunction is poorly understood because relatively few studies have been done in community settings. In the United States, female sexual dysfunction has been estimated to affect 40% of women in the general population. Among the elderly, however, it has been reported that up to 87% of women complain of sexual dissatisfaction. Several studies have shown that the prevalence of female sexual arousal disorders correlates significantly with increasing age. These studies have shown that sexual arousal and frequency of coitus in the female decreases with increasing age. The pathophysiology of female sexual dysfunction appears more complex than that of males, involving multidimensional hormonal, neurological, vascular, psychological, and interpersonal aspects. Organic female sexual disorders may include a wide variety of vascular, neural, or neurovascular factors that lead to problems with libido, lubrication, and orgasm. However, the precise etiology and mechanistic pathways of age-related female sexual arousal disorders are yet to be determined. In the past two decades, some advances have been made in exploring the basic hemodynamics and neuroregulation of female sexual function and dysfunction in both animal models and in human studies. In this review, we summarize neural regulation of sexual function and neurological causes of sexual dysfunction in women.

Keyword

Arousal; Clitoris; Female; Nerve; Vagina

MeSH Terms

Aged
Arousal
Clitoris
Coitus
Epidemiology
Female
Hemodynamics
Humans
Libido
Lubrication
Male
Models, Animal
Orgasm
Physiology
Prevalence
Sexual Dysfunctions, Psychological
United States
Vagina

Reference

1. O'Connell HE, Hutson JM, Anderson CR, Plenter RJ. Anatomical relationship between urethra and clitoris. J Urol. 1998. 159:1892–1897.

2. Rees MA, O'Connell HE, Plenter RJ, Hutson JM. The suspensory ligament of the clitoris: connective tissue supports of the erectile tissues of the female urogenital region. Clin Anat. 2000. 13:397–403.

3. Ingelman-Sundberg A. The anterior vaginal wall as an organ for the transmission of active forces to the urethra and the clitoris. Int Urogynecol J Pelvic Floor Dysfunct. 1997. 8:50–51.

4. Toesca A, Stolfi VM, Cocchia D. Immunohistochemical study of the corpora cavernosa of the human clitoris. J Anat. 1996. 188:513–520.

5. Baskin LS, Erol A, Li YW, Liu WH, Kurzrock E, Cunha GR. Anatomical studies of the human clitoris. J Urol. 1999. 162:1015–1020.

6. Burnett AL, Calvin DC, Silver RI, Peppas DS, Docimo SG. Immunohistochemical description of nitric oxide synthase isoforms in human clitoris. J Urol. 1997. 158:75–78.

7. Cocchia D, Rende M, Toesca A, Viola R, Stolfi VM. Immunohistochemical study of neuropeptide Y-containing nerve fibers in the human clitoris and penis. Cell Biol Int Rep. 1990. 14:865–875.

8. Hauser-Kronberger C, Cheung A, Hacker GW, Graf AH, Dietze O, Frick J. Peptidergic innervation of the human clitoris. Peptides. 1999. 20:539–543.

9. van Turnhout AA, Hage JJ, van Diest PJ. The female corpus spongiosum revisited. Acta Obstet Gynecol Scand. 1995. 74:767–771.

10. Shabsigh A, Buttyan R, Burchardt T, Buchardt M, Hayek OR, D'Agati V, et al. The microvascular architecture of the rat vagina revealed by image analysis of vascular corrosion casts. Int J Impot Res. 1999. 11:Suppl 1. S23–S30.

11. Peters LC, Kristal MB, Komisaruk BR. Sensory innervation of the external and internal genitalia of the female rat. Brain Res. 1987. 408:199–204.

12. Traurig H, Saria A, Lembeck F. Substance P in primary afferent neurons of the female rat reproductive system. Naunyn Schmiedebergs Arch Pharmacol. 1984. 326:343–346.

13. Lakomy M, Kaleczyc J, Majewski M, Sienkiewicz W. Peptidergic innervation of the bovine vagina and uterus. Acta Histochem. 1995. 97:53–66.

14. Berman JR, McCarthy MM, Kyprianou N. Effect of estrogen withdrawal on nitric oxide synthase expression and apoptosis in the rat vagina. Urology. 1998. 51:650–656.

15. Hoyle CH, Stones RW, Robson T, Whitley K, Burnstock G. Innervation of vasculature and microvasculature of the human vagina by NOS and neuropeptide-containing nerves. J Anat. 1996. 188:633–644.

16. Blank MA, Gu J, Allen JM, Huang WM, Yiangou Y, Ch'ng J, et al. The regional distribution of NPY-, PHM-, and VIP-containing nerves in the human female genital tract. Int J Fertil. 1986. 31:218–222.

17. Sommer F, Caspers HP, Esders K, Klotz T, Engelmann U. Measurement of vaginal and minor labial oxygen tension for the evaluation of female sexual function. J Urol. 2001. 165:1181–1184.

18. Henson DE, Rubin HB, Henson C. Labial and vaginal blood volume responses to visual and tactile stimuli. Arch Sex Behav. 1982. 11:23–31.

19. Park K, Goldstein I, Andry C, Siroky MB, Krane RJ, Azadzoi KM. Vasculogenic female sexual dysfunction: the hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. Int J Impot Res. 1997. 9:27–37.

20. Ottesen B, Pedersen B, Nielsen J, Dalgaard D, Wagner G, Fahrenkrug J. Vasoactive intestinal polypeptide (VIP) provokes vaginal lubrication in normal women. Peptides. 1987. 8:797–800.

21. Levin RJ. VIP, vagina, clitoral and periurethral glans--an update on human female genital arousal. Exp Clin Endocrinol. 1991. 98:61–69.

22. Levin RJ, Wagner G. Orgasm in women in the laboratory--quantitative studies on duration, intensity, latency, and vaginal blood flow. Arch Sex Behav. 1985. 14:439–449.

23. Wagner G, Ottesen B. Vaginal blood flow during sexual stimulation. Obstet Gynecol. 1980. 56:621–624.

24. Lavoisier P, Aloui R, Schmidt MH, Watrelot A. Clitoral blood flow increases following vaginal pressure stimulation. Arch Sex Behav. 1995. 24:37–45.

25. Vachon P, Simmerman N, Zahran AR, Carrier S. Increases in clitoral and vaginal blood flow following clitoral and pelvic plexus nerve stimulations in the female rat. Int J Impot Res. 2000. 12:53–57.

26. Wagner G, Levin RJ. Effect of atropine and methylatropine on human vaginal blood flow, sexual arousal and climax. Acta Pharmacol Toxicol (Copenh). 1980. 46:321–325.

27. Vemulapalli S, Kurowski S. Sildenafil relaxes rabbit clitoral corpus cavernosum. Life Sci. 2000. 67:23–29.

28. McIntosh TK, Barfield RJ. Brain monoaminergic control of male reproductive behavior. I. Serotonin and the post-ejaculatory refractory period. Behav Brain Res. 1984. 12:255–265.

29. Min K, Kim NN, McAuley I, Stankowicz M, Goldstein I, Traish AM. Sildenafil augments pelvic nerve-mediated female genital sexual arousal in the anesthetized rabbit. Int J Impot Res. 2000. 12:Suppl 3. S32–S39.

30. Wagner G, Levin R. Oxygen tension of the vaginal surface during sexual stimulation in the human. Fertil Steril. 1978. 30:50–53.

31. Palle C, Bredkjaer HE, Ottesen B, Fahrenkrug J. Peptide histidine methionine (PHM) increases vaginal blood flow in normal women. Peptides. 1990. 11:401–404.

32. Tarcan T, Siroky MB, Park K, Goldstein I, Azadzoi KM. Systemic administration of apomorphine improves the hemodynamic mechanism of clitoral and vaginal engorgement in the rabbit. Int J Impot Res. 2000. 12:235–240.

33. Abel GG, Murphy WD, Becker JV, Bitar A. Women's vaginal responses during REM Sleep. J Sex Marital Ther. 1979. 5:5–14.

34. Smock T, Albeck D, Stark P. A peptidergic basis for sexual behavior in mammals. Prog Brain Res. 1998. 119:467–481.

35. Blaicher W, Gruber D, Bieglmayer C, Blaicher AM, Knogler W, Huber JC. The role of oxytocin in relation to female sexual arousal. Gynecol Obstet Invest. 1999. 47:125–126.

36. Goldstein I, Graziottin A, Heiman JR. Jardin A, Wagner G, Khoury S, Guiliano F, editors. Female sexual dysfunction. Erectile dysfunction. 2000. Playmouth: Plymbridge Disritbutors;509–556.

37. Giuliano F, Allard J, Compagnie S, Alexandre L, Droupy S, Bernabe J. Vaginal physiological changes in a model of sexual arousal in anesthetized rats. Am J Physiol Regul Integr Comp Physiol. 2001. 281:R140–R149.

38. Hilliges M, Falconer C, Ekman-Ordeberg G, Johansson O. Innervation of the human vaginal mucosa as revealed by PGP 9.5 immunohistochemistry. Acta Anat. 1995. 153:119–126.

39. Moore KL, Persaud TV. The developing human: clinically oriented embryology. 1998. 6th ed. Philadelphia: Saunders;330–331.

40. Azadzoi KM, Tarcan T, Kim N, Siroky MB, Krane RJ, Goldstein I. Regulatory mechanism of clitoral cavernosal and vaginal smooth muscle contractility in the rabbit. J Urol. 1998. 159:355.

41. Al-Hijji J, Larsson B, Batra S. Nitric oxide synthase in the rabbit uterus and vagina: hormonal regulation and functional significance. Biol Reprod. 2000. 62:1387–1392.

42. Helm G, Ottesen B, Fahrenkrug J, Larsen JJ, Owman C, Sjoberg NO, et al. Vasoactive intestinal polypeptide (VIP) in the human female reproductive tract: distribution and motor effects. Biol Reprod. 1981. 25:227–234.

43. Bredkjoer HE, Palle C, Ekblad E, Fahrenkrug J, Ottesen B. PreproVIP-derived peptides in the human female genital tract: expression and biological function. Neuropeptides. 1997. 31:209–215.

44. Park JK, Kim SZ, Kim SH, Kim YG, Cho KW. Renin angiotensin system of rabbit clitoral cavernosum: interaction with nitric oxide. J Urol. 2000. 164:556–561.

45. Vroege JA, Gijs L, Hengeveld MW. Classification of sexual dysfunctions: towards DSM-V and ICD-11. Compr Psychiatry. 1998. 39:333–337.

46. Leiblum SR. Definition and classification of female sexual disorders. Int J Impot Res. 1998. 10:Suppl 2. S104–S106.

47. World Health Organization. International statistical classification of diseases and related health problems. 1992. Geneva: The Organization.

48. Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J, et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol. 2000. 163:888–893.

49. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999. 281:537–544.

50. Rosen RC, Taylor JF, Leiblum SR, Bachmann GA. Prevalence of sexual dysfunction in women: results of a survey study of 329 women in an outpatient gynecological clinic. J Sex Marital Ther. 1993. 19:171–188.

51. Sipski ML, Alexander CJ. Sexual activities, response and satisfaction in women pre- and post-spinal cord injury. Arch Phys Med Rehabil. 1993. 74:1025–1029.

52. Sipski ML, Alexander CJ, Rosen RC. Physiological parameters associated with psychogenic sexual arousal in women with complete spinal cord injuries. Arch Phys Med Rehabil. 1995. 76:811–818.

53. Sipski ML, Alexander CJ, Rosen R. Sexual arousal and orgasm in women: effects of spinal cord injury. Ann Neurol. 2001. 49:35–44.

54. Sipski ML, Alexander CJ, Rosen RC. Sexual response in women with spinal cord injuries: implications for our understanding of the able bodied. J Sex Marital Ther. 1999. 25:11–22.

55. Prather RC. Sexual dysfunction in the diabetes female: a review. Arch Sex Behav. 1988. 17:277–284.

56. Schreiner-Engel P, Schiavi RC, Vietorisz D, De Simone Eichel J, Smith H. Diabetes and female sexuality: a comparative study of women in relationships. J Sex Marital Ther. 1985. 11:165–175.

57. Tyrer G, Steel JM, Ewing DJ, Bancroft J, Warner P, Clarke BF. Sexual responsiveness in diabetic women. Diabetologia. 1983. 24:166–171.

58. Jensen SB. Diabetic sexual dysfunction: a comparative study of 160 insulin treated diabetic men and women and an age-matched control group. Arch Sex Behav. 1981. 10:493–504.

59. Enzlin P, Mathieu C, Vanderschueren D, Demyttenaere K. Diabetes mellitus and female sexuality: a review of 25 years' research. Diabet Med. 1998. 15:809–815.

60. Leedom L, Feldman M, Procci W, Zeidler A. Symptoms of sexual dysfunction and depression in diabetic women. J Diabet Complications. 1991. 5:38–41.

61. LeMone P. The physical effects of diabetes on sexuality in women. Diabetes Educ. 1996. 22:361–366.

62. Wincze JP, Albert A, Bansal S. Sexual arousal in diabetic females: physiological and self-report measures. Arch Sex Behav. 1993. 22:587–601.

63. Erol B, Tefekli A, Sanli O, Ziylan O, Armagan A, Kendirci M, et al. Does sexual dysfunction correlate with deterioration of somatic sensory system in diabetic women? Int J Impot Res. 2003. 15:198–202.

64. Sax DS, Berman JR, Goldstein I. Female neurogenic sexual dysfunction secondary to clitoral neuropathy. J Sex Marital Ther. 2001. 27:599–602.

65. Romanzi LJ, Groutz A, Feroz F, Blaivas JG. Evaluation of female external genitalia sensitivity to pressure/touch: a preliminary prospective study using Semmes-Weinstein monofilaments. Urology. 2001. 57:1145–1150.

66. Amarenco G, Ismael SS, Bayle B, Denys P, Kerdraon J. Electrophysiological analysis of pudendal neuropathy following traction. Muscle Nerve. 2001. 24:116–119.

67. Amarenco G, Kerdraon J, Albert T, Denys P. Stretch neuropathy of the internal pudendal nerve. Its relationship to urinary incontinence, anorectal, and genito-sexual disorders in women. Contracept Fertil Sex. 1994. 22:235–238.

68. Spector IP, Carey MP. Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav. 1990. 19:389–408.